A detailed history of Cx Institutional transactions in Johnson & Johnson stock. As of the latest transaction made, Cx Institutional holds 49,167 shares of JNJ stock, worth $7.17 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
49,167
Previous 36,311 35.41%
Holding current value
$7.17 Million
Previous $5.31 Million 50.14%
% of portfolio
0.36%
Previous 0.25%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$145.48 - $167.38 $1.87 Million - $2.15 Million
12,856 Added 35.41%
49,167 $7.97 Million
Q2 2024

Jul 11, 2024

SELL
$144.38 - $157.78 $533,195 - $582,681
-3,693 Reduced 9.23%
36,311 $5.31 Million
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $827,788 - $867,892
5,333 Added 15.38%
40,004 $6.33 Million
Q4 2023

Jan 12, 2024

BUY
$145.6 - $158.88 $3,494 - $3,813
24 Added 0.07%
34,671 $5.43 Million
Q3 2023

Oct 17, 2023

BUY
$155.75 - $174.48 $2.21 Million - $2.48 Million
14,192 Added 69.38%
34,647 $5.4 Million
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $216,861 - $233,384
1,405 Added 7.38%
20,455 $3.39 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $115,251 - $137,538
763 Added 4.17%
19,050 $2.95 Million
Q4 2022

Feb 03, 2023

BUY
$160.2 - $179.79 $93,396 - $104,817
583 Added 3.29%
18,287 $3.23 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $1.88 Million - $2.09 Million
-11,633 Reduced 39.65%
17,704 $2.89 Million
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $57,184 - $63,243
340 Added 1.17%
29,337 $5.21 Million
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $438,680 - $498,182
-2,774 Reduced 8.73%
28,997 $5.14 Million
Q4 2021

Jan 18, 2022

SELL
$155.93 - $173.01 $733,962 - $814,358
-4,707 Reduced 12.9%
31,771 $5.44 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $140,505 - $156,138
870 Added 2.44%
36,478 $5.89 Million
Q2 2021

Aug 04, 2021

SELL
$159.48 - $171.07 $47,206 - $50,636
-296 Reduced 0.82%
35,608 $5.87 Million
Q1 2021

Apr 15, 2021

BUY
$153.07 - $170.48 $70,106 - $78,079
458 Added 1.29%
35,904 $5.9 Million
Q4 2020

Jan 12, 2021

SELL
$137.11 - $157.38 $61,151 - $70,191
-446 Reduced 1.24%
35,446 $5.58 Million
Q3 2020

Oct 13, 2020

BUY
$140.38 - $153.83 $3.01 Million - $3.3 Million
21,468 Added 148.84%
35,892 $5.34 Million
Q2 2020

Aug 06, 2020

BUY
$128.81 - $155.51 $150,321 - $181,480
1,167 Added 8.8%
14,424 $2.03 Million
Q1 2020

Apr 29, 2020

SELL
$111.14 - $153.99 $794,317 - $1.1 Million
-7,147 Reduced 35.03%
13,257 $1.74 Million
Q4 2019

Jan 21, 2020

BUY
$127.5 - $146.44 $1.02 Million - $1.17 Million
8,022 Added 64.79%
20,404 $2.98 Million
Q3 2019

Oct 10, 2019

SELL
$126.95 - $142.14 $48,748 - $54,581
-384 Reduced 3.01%
12,382 $1.6 Million
Q2 2019

Jul 17, 2019

BUY
$131.15 - $144.24 $72,788 - $80,053
555 Added 4.55%
12,766 $1.78 Million
Q1 2019

Apr 03, 2019

BUY
$125.72 - $139.79 $173,493 - $192,910
1,380 Added 12.74%
12,211 $1.71 Million
Q4 2018

Jan 14, 2019

BUY
$122.84 - $147.84 $1.21 Million - $1.45 Million
9,831 Added 983.1%
10,831 $1.4 Million
Q2 2018

Jul 12, 2018

BUY
$119.4 - $131.76 $40,834 - $45,061
342 Added 51.98%
1,000 $121,000
Q2 2018

Jul 12, 2018

BUY
$119.4 - $131.76 $78,565 - $86,698
658 New
658 $84,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.